As of 2025-03-21, the Relative Valuation of Revive Therapeutics Ltd (RVV.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Revive Therapeutics Ltd based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-03-18 | -0.18 |
| 2025-03-17 | -0.37 |
| 2025-03-12 | -0.18 |
| 2025-03-11 | -0.37 |
| 2025-03-10 | -0.18 |
| 2025-03-07 | -0.18 |
| 2025-03-06 | -0.18 |
| 2025-03-04 | -0.37 |
| 2025-03-03 | -0.37 |
| 2025-02-28 | -0.37 |
| 2025-02-27 | -0.37 |
| 2025-02-26 | -0.37 |
| 2025-02-25 | -0.37 |
| 2025-02-24 | -0.37 |
| 2025-02-21 | -0.37 |
| 2025-02-19 | -0.37 |
| 2025-02-18 | -0.37 |
| 2025-02-14 | -0.37 |
| 2025-02-13 | -0.37 |
| 2025-02-12 | -0.37 |
| 2025-02-11 | -0.37 |
| 2025-02-07 | -0.37 |
| 2025-02-06 | -0.37 |
| 2025-02-05 | -0.37 |
| 2025-02-04 | -0.37 |
| 2025-02-03 | -0.37 |
| 2025-01-31 | -0.37 |
| 2025-01-30 | -0.37 |
| 2025-01-29 | -0.37 |
| 2025-01-28 | -0.37 |
| 2025-01-27 | -0.37 |
| 2025-01-24 | -0.37 |
| 2025-01-23 | -0.37 |
| 2025-01-22 | -0.37 |
| 2025-01-21 | -0.37 |
| 2025-01-20 | -0.18 |
| 2025-01-17 | -0.37 |
| 2025-01-16 | -0.37 |
| 2025-01-15 | -0.37 |
| 2025-01-13 | -0.18 |
| 2025-01-10 | -0.37 |
| 2025-01-09 | -0.37 |
| 2025-01-08 | -0.18 |
| 2025-01-06 | -0.18 |
| 2025-01-03 | -0.37 |
| 2025-01-02 | -0.37 |
| 2024-12-31 | -0.37 |
| 2024-12-30 | -0.18 |
| 2024-12-27 | -0.37 |
| 2024-12-24 | -0.37 |